145020 - Hugel, Inc.

145020 Summary
Biopharma
Stock Price & Overview
₩244,000 +3,500 (+1.46%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩244,000  ≈ US$174  ·  Market cap ₩3.1tn (≈ $2.2bn)

145020 Stock Price

250K300Kprev 241Kpeak 335KOctNovDecJan ’26FebMarAprMayJunJulAugSep244K
52 Week Range
₩214,000₩335,000
Day Range
₩240,500₩245,000
Market Cap
₩3.1tn
P/E (TTM)
18.71x
P/B
2.81x
P/S (TTM)
6.37x
P/CF (TTM)
16.83x
Volume
27,884
Shares Out
12.5M
Prev. Close
₩240,500
vs 52W High
-27.2%
Multiples use the close and the financials that were public on that date (DART), the same series as the Valuation tab — they are not vendor figures.

145020 Analysis

See all »

Nothing written yet for this company.

145020 News

See all »

No news written yet.

145020 Momentum

Period145020KOSDAQDifference
1 week-5.8%-3.0%-2.8%
1 month-5.4%+4.2%-9.6%
3 months-3.0%-22.5%+19.5%
6 months+4.3%-16.9%+21.1%
Year to date+5.9%-12.1%+18.0%
1 year-26.9%+1.0%-27.9%

Closed at 25% of the way from its 52-week low (₩214,000) to its 52-week high (₩335,000).

Price return on KRX closes, KOSDAQ on the same dates, no dividends. A period starts at the last trading day on or before the calendar date.

145020 Filings

See all »
DART

Large business group status disclosure — quarterly, individual company

Filing08/31/26title translated
DART

Results of an extraordinary general meeting

Filing08/24/26title translated
DART

Insider / Major Shareholder Holdings Report

Ownership08/21/26title translated
DART

Appointment, dismissal or early departure of an independent director

Filing08/21/26title translated
Korean issuers file to DART, not the SEC. Titles are translated; where kstock has read the filing the row carries the explanation.

145020 Company Profile

Hugel, Inc. makes pharmaceutical ingredients in South Korea. It is listed on KOSDAQ, was founded in 2001, is based in Gangwon, and has revenue of hundreds of billions of won.

SectorBiopharmaEmployees
MarketKOSDAQFounded2001
Korean name휴젤Head officeGangwon

Similar to 145020

SymbolLast Price
298380ABL Bio Inc.₩71,400
+5.6%
000250Samchundang Pharm₩157,000
+1.0%
087010Peptron, Inc.₩157,300
+7.3%
141080LigaChem Biosciences Inc.₩92,000
+4.2%
302440SK Bioscience Co., Ltd.₩37,900
+0.4%
009420Hanall Biopharma Co., Ltd.₩54,700
+1.5%
310210Voronoi, Inc.₩153,000
+3.9%
214370Caregen Co., Ltd.₩44,500
+1.5%
347850D & D Pharmatech, Inc.₩49,200
+1.4%
237690ST Pharm Co., Ltd.₩101,200
+2.2%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.